Icon Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,809
Closed -$144K 467
2023
Q4
$144K Buy
+2,809
New +$147K 0.02% 360
2022
Q4
Sell
-2,110
Closed -$150K 340
2022
Q3
$150K Buy
+2,110
New +$153K 0.02% 335

Other funds holding BMY

Icon Wealth Advisors's BMY Position: Q1 2024 in Review

Icon Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 2,809 shares — an estimated $144K sold.

Icon Wealth Advisors first reported a position in BMY in Q3 2022 and held it in 2 quarters. The position peaked at $150K in Q3 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Icon Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Icon Wealth Advisors sold 2,809 Bristol-Myers Squibb shares in Q1 2024, an estimated $144K.
  • Icon Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 2 quarters.
  • Icon Wealth Advisors's Bristol-Myers Squibb position peaked at $150K in Q3 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Icon Wealth Advisors's 13F filing for Q1 2024, filed 15 May 2024.